Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial. - Yu, Ke‐Da; Wu, Si‐Yu; Liu, Guang‐Yu; Wu, Jiong; Di, Gen‐Hong; Hu, Zhen; Hou, Yi‐Feng; Chen, Can‐Ming; Fan, Lei; Tang, Li‐Chen; Shen, Zhen‐Zhou; Wu, Ke‐Jin; et al. (Cancer (0008543X), 2019)